window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : August 12, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Research & Development

  • Central Nervous System,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    ABLi reports biomarker changes supporting disease-modifying potential of Parkinson’s drug

    ABLi Therapeutics has reported coordinated changes across 11 biomarkers linked [...]

    August 4, 2026
  • Digital & Data,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    AI model cuts radiopharmaceutical dose mapping to seconds in prostate cancer study

    A new AI model has generated patient-specific radiation dose-rate maps [...]

    August 5, 2026
  • Drug Delivery & Formulation,Manufacturing & Supply Chain,Research & Development

    Piramal Pharma Solutions expands peptide API facility with spray drying suite

    Piramal Pharma Solutions has expanded its dedicated peptide development and [...]

    August 4, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Research & Development

    QuantHealth raises $45M Series B to expand AI clinical trial simulation

    QuantHealth has raised $45 million in a Series B funding [...]

    August 4, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Research & Development

    Circio advances circular RNA gene therapy platform towards clinical development

    Circio is preparing to advance its circular RNA gene therapy [...]

    August 4, 2026
  • Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    National Health Council launches Detroit campaign to address kidney screening gap

    The National Health Council has launched a Detroit pilot campaign [...]

    August 5, 2026
  • Genomics and sequencing,Manufacturing & Supply Chain,Research & Development

    DNA Script and GE HealthCare awarded up to $26M for DNA bioproduction programme

    DNA Script and GE HealthCare are developing an automated platform [...]

    August 4, 2026
  • Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Vaximm reports encouraging VXM01 data in recurrent glioblastoma studies

    Vaximm AG has completed analysis of two clinical studies evaluating [...]

    August 3, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Genomics and sequencing,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Medicus Pharma gets UAE approval to start genomics-guided endometriosis study

    Medicus Pharma has received authorisation from the UAE Department of [...]

    July 31, 2026
  • Advanced Therapies,Clinical & Regulatory,Manufacturing & Supply Chain,Research & Development

    First UK patient dosed in personalised lung cancer vaccine trial using Touchlight DNA technology

    The first UK patient has been dosed with a personalised [...]

    July 30, 2026
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • FDA backs registration pathway for Obsidian’s melanoma TIL therapy
    Categories: Advanced Therapies, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
  • AC Immune advances Parkinson’s and Alzheimer’s pipeline with key clinical milestones ahead
    Categories: Central Nervous System, Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • NEB launches cell-free RNA extraction kit for liquid biopsy research Slug: neb-c
    Categories: Drug Discovery & Development, Genomics and sequencing, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top